GlassScriptPhysician profile
Yogesh Jonna
NPI 1477086189
$10,995.80
in general payments reported to CMS, 2019-2025
30 companies · $3,033 in 2025
The $3,033 reported for 2025 was more than what 75% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $534 · 2022: $844 · 2023: $4,626 · 2024: $1,959 · 2025: $3,033.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,664 · Grant: $4,000 · Travel and Lodging: $953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,664.40 |
| Grant | $4,000.00 |
| Travel and Lodging | $953.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,443.27 | 2023-2025 | Turbohawk, Corevalve Evolut R, Symplicity G3 |
| Boston Scientific Corporation | $2,412.12 | 2021-2025 | General - Vascular Access, Stingray, Avvigo Guidance System |
| Inari Medical, INC. | $741.89 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiovascular Systems INC. | $553.58 | 2021-2022 | |
| Abbott Laboratories | $474.53 | 2024-2025 | Cardiomems, Esprit |
| Philips North America LLC | $440.50 | 2024-2025 | Coronary Other, (Ck7) Extended Holter |
| Abiomed | $344.01 | 2024-2025 | Impella |
| Teleflex LLC | $202.27 | 2025 | Guideliner, Manta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $166.12 | 2021-2025 | Lifevest |
| Shockwave Medical, INC | $126.72 | 2022 | |
| Penumbra, INC. | $123.55 | 2024 | Indigo System |
| Chiesi USA, INC. | $122.47 | 2023-2025 | Kengreal, Cleviprex |
| Endologix LLC | $107.88 | 2025 | Alto Abdominal Stent Graft System |
| Amgen INC. | $104.45 | 2023-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $91.44 | 2024-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $72.51 | 2023-2024 | Pascal, Evoque |
| Astrazeneca Pharmaceuticals LP | $68.24 | 2021-2025 | Lokelma |
| Angiodynamics, INC. | $65.66 | 2025 | Alphavac |
| Novo Nordisk INC | $53.46 | 2025 | Wegovy |
| Terumo Medical Corporation | $46.24 | 2023 | Optitorque, Heartrail, Glidewire |
| Pfizer INC. | $44.85 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $41.46 | 2023 | Verquvo |
| Surmodics, INC. | $22.80 | 2024 | Pounce LP Thrombectomy |
| Janssen Pharmaceuticals, INC | $22.74 | 2024 | Xarelto |
| Stryker Corporation | $20.54 | 2025 | Artix Mt |
| Argon Medical Devices, INC. | $20.39 | 2025 | Clot Management |
| Imperative Care, INC | $17.43 | 2025 | Symphony Catheter |
| Cordis US Corp. | $16.50 | 2024 | Mynx Venous Vcd |
| Kiniksa Pharmaceuticals International, Plc | $14.18 | 2024 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $14.00 | 2024 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yogesh Jonna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.